NEW YORK ( TheStreet) -- CHANGE IN RATINGS Adobe ( ADBE) was upgraded at FBR Capital Markets to market perform from underperform. Negative catalysts have already played out, FBR Capital Markets said. BorgWarner ( BWA) was upgraded at Robert Baird to outperform from neutral. $107 price target. Earnings growth is set to accelerate, Baird said. BRT Realty Trust ( BRT) was upgraded to hold at TheStreet Ratings. FMC Technologies ( FTI) was downgraded at Bank of America/Merrill Lynch to neutral from buy. Price target is $62. Slowing growth and the potential loss of the Block 32 project could hurt future earnings, BofA/Merrill Lynch said. HOLX) was downgraded at Piper Jaffray to neutral from overweight. Legacy mammography business should be a drag on growth, Piper Jaffray said. $21 price target. Iteris ( ITI) was upgraded to buy at TheStreet Ratings. Johnson & Johnson ( JNJ) was downgraded at Deutsche Bank to neutral from buy. Price target is $93. Major catalysts and improving fundamentals have been priced into the stock, Deutsche Bank said. Medivation ( MDVN) was upgraded at UBS to buy from neutral and given a $74 price target, said UBS. The upgrade comes ahead of the ph3 PREVAIL study, UBS said. Packaging Corp. ( PKG) was downgraded at BMO Capital to market perform from outperform. Price target was increased to $55. Stock is trading at a premium to its seven-year average and the majority of its competition, BMO Capital said. SNI) was downgraded at Wunderlich to hold from buy. Valuation call, based on a $77 price target, Wunderlich said. Time Warner Telecom ( TWTC) was downgraded at Deutsche Bank to hold from buy. Valuation call, Deutsche Bank said.
Gilead ( GILD) estimates, price target were increased at Oppenheimer. Estimates were raised through 2014. Company can gain market share in Genotype 1 HCV, Oppenheimer said. Outperform rating and new $63 price target. Goldman Sachs ( GS) numbers raised at UBS. Earnings estimates were raised given better revenue outlook and buybacks, said UBS. Price target goes to $165. Johnson & Johnson ( JNJ) numbers were boosted at Jefferies. Shares are now seen reaching $95. Estimates also upped, given better pharmaceuticals growth, Jefferies said. Hold rating. Starbucks ( SBUX) price target was raised at Oppenheimer. Shares are now seen reaching $75. Company can continue to deliver strong sales and expand margins, Oppenheimer said. Outperform rating. Charles Schwab ( SCHW) numbers were raised at UBS. Earnings estimates were raised given NIM upside, said UBS. Price target goes to $21. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.